Search - tctmd.com

Displaying 721 - 740 of 1104

Sort: Relevancy | Date

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Conference News ESC 2013

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Caitlin E. Cox

September 02, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

News Daily News

控制良好的华法林不会降低三联疗法出血风险

August 30, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Presentation

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

Presenter: Y. Naruse

August 26, 2013

News Daily News

Remote Preconditioning Before CABG Reduces Not Only Myocardial Injury but Also Mortality

Caitlin E. Cox

August 23, 2013

News Daily News

Oral Sirolimus Appears to Augment Efficacy of BMS

Caitlin E. Cox

August 23, 2013

News Daily News

El Sirolimus Oral Parece Aumentar la Eficacia de los SMD

August 23, 2013

News Daily News

El Preacondicionamiento Remoto Previo a una CABG Reduce las Lesiones Miocárdicas y la Mortalidad

Caitlin E. Cox

August 23, 2013

Presentation

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

Presenter: Tarun W. Dasari

August 21, 2013

News Daily News

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

Caitlin E. Cox

August 12, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

News Daily News

El Apixaban Beneficia a los Pacientes con FA con Independencia del Uso Previo de Warfarina

Jason Kahn

August 06, 2013

News Daily News

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

Jason Kahn

August 06, 2013

News Daily News

Quitting Smoking After PCI Can Add Years to Patients’ Lives

L.A. McKeown

August 05, 2013

Advertisement

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

控制良好的华法林不会降低三联疗法出血风险

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

Remote Preconditioning Before CABG Reduces Not Only Myocardial Injury but Also Mortality

Oral Sirolimus Appears to Augment Efficacy of BMS

El Sirolimus Oral Parece Aumentar la Eficacia de los SMD

El Preacondicionamiento Remoto Previo a una CABG Reduce las Lesiones Miocárdicas y la Mortalidad

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

El Apixaban Beneficia a los Pacientes con FA con Independencia del Uso Previo de Warfarina

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

Quitting Smoking After PCI Can Add Years to Patients’ Lives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content